Arsenic-contaminated drinking water and cholangiocarcinoma
- PMID: 35044987
- DOI: 10.1097/CEJ.0000000000000740
Arsenic-contaminated drinking water and cholangiocarcinoma
Abstract
Introduction: Cholangiocarcinoma (CCA) is an aggressive tumor occurring in bile ducts and associated with dismal outcomes. It can be classified according to anatomical location as intrahepatic cholangiocarcinoma (ICC) or extrahepatic cholangiocarcinoma (ECC). Although some risk factors have been identified, our understanding of these tumors remains limited. Arsenic (As) is a prevalent toxicant with established associations with bladder, skin and lung cancers while pilot data on its potential carcinogenic role on digestive tumors are emerging. This ecological study aimed to investigate the association between exposure to As-contaminated drinking water and CCA.
Methods: Analyses were conducted for the US, Taiwan and India due to the quality of publicly available datasets including small area-level information. Statistics included coefficient correlations analyses as well as univariate and multivariate linear regressions.
Results: In the US, no correlation was observed between As and CCA. In Taiwan, correlations were identified for ICC in men (Spearman = 0.55, P = 0.01) and women (Spearman = 0.67, P < 0.01), as well as for ECC in men (Spearman = 0.62, P < 0.01). In India, counties with As level of at least 50 µg/L showed higher incidences of ECC in men ( R2 = 0.26, P = 0.01) and women ( R2 = 0.31, P < 0.01).
Conclusion: These findings highlighted a potential carcinogenic impact of As in drinking water on bile duct cancers, paving the way for future studies aiming to replicate this association with individual data as well as its clinical and ecological implications.
Copyright © 2022 Wolters Kluwer Health, Inc. All rights reserved.
References
-
- American Cancer Society (n.d.). Survival rates for bile duct cancer. Available at: https://www.cancer.org/cancer/bile-duct-cancer/detection-diagnosis-stagi... [Accessed 15 December 2019]
-
- Antwi S, Mousa O, Patel T (2018). Racial, ethnic, and age disparities in incidence and survival of intrahepatic cholangiocarcinoma in the United States; 1995-2014. Annals of Hepatology 17:274–285.
-
- Bertuccio P, Malvezzi M, Carioli G, Hashim D, Boffetta P, El-Serag HB, et al. (2019). Global trends in mortality from intrahepatic and extrahepatic cholangiocarcinoma. J Hepatol 71:104–114.
-
- Bray F, Colombet M, Mery L, Pineros M, Znaor A, Zanetti R, et al. (2017). Cancer incidence in five continents. Vol. XI (electronic version). 2017, Lyon: International Agency for Research on Cancer.
-
- Frey MM, Edwards MA (1997). Surveying arsenic occurrence. J Am Water Works Assoc 89:105–117.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials